Colossal Biosciences creates technologies for species restoration, critically endangered species protection, and the repopulation of critical ecosystems that support the continuation of life on Earth.

Induced pluripotent stem cells (iPSCs) are a “starting material grail” for advanced therapies. That’s according to Sven Kili, chief development officer at CCRM, the Canadian regenerative medicine ...

Flow cytometers, droplet dispensers, and limiting dilution techniques aimed at depositing a single iPSC in a well, often create a strenuous and unnatural environment that leads to low clonal survival ...

New methods for deriving macrophages from induced pluripotent stem cells are easier to scale and provide more clinically relevant data. Induced pluripotent stem cells (iPSCs) have given scientists ...

AMSBIO (Milton, UK) has launched a range of genetically engineered Induced Pluripotent Stem Cells (iPSCs) developed to provide improved model fidelity over cell lines and biochemical assays used for ...

SmartCella and Catalent have entered a nonexclusive license agreement for induced pluripotent stem cells (iPSCs) for developing regenerative therapies ...

Cystic fibrosis (CF) is caused by a mutation of the CFTR gene. While there are many hundreds of known mutations, not all of them are currently treatable which means a significant number of CF patients ...

Japanese scientists led by Shin Kaneko, an associate professor in the Center for iPS Cell Research and Application (CiRA) at Kyoto University, have developed the first practical bioengineering ...

But not long into this new endeavor, “something important happened in the field,” Tischfield recalled. Researchers reported for the first time that they could induce pluripotency from blood cells. It ...

According to the Alliance for Regenerative Medicine, more than 1300 clinical studies for regenerative medicine and advanced therapies, including autologous and allogeneic cell therapies, are ongoing ...